You may not log in without verifying your email address.
Please check your email (including your spam email) for the Welcome message that was sent.
N(5)-(1-Iminoethyl)-L-ornithine HCl (L-NIO), is an inhibitor of NOS3 (nitric oxide synthase) in the vascular endothelium that can halt endothelium-dependent relaxation induced by acteylcholine and cause endothelium-dependent contraction in aortic rings. Mechanistic studies have noted that L-NIO inhibits Ca2+-dependent NOS3 (eNOS). The same experiment on rat aorta has shown L-NIO to display a capacity to induce a dose-dependent increase in mean systemic arterial blood pressure. In addition, research has shown L-NIO to be the most potent inhibitor of the neutrophil and J774 enzymes compared to its analogues L-NMMA, L-NAME, and L-NNA.
1. Palacios, M., et al. 1989. Biochem. Biophys. Res. Commun. 165: 802-809. PMID: 2480784
2. Rees, D.D., et al. 1990. Br. J. Pharmacol. 101: 746-752. PMID: 1706208
3. McCall, T.B., et al. 1991. Br. J. Pharmacol. 102: 234-238. PMID: 1710525
4. Moore, W.M., et al. 1994. J. Med. Chem. 37: 3886-3888. PMID: 7525961
See how others have used N(5)-(1-Iminoethyl)-L-ornithine HCl (L-NIO). Click on the entry to view the PubMed entry .
PMID: # 27158388 Xu, Z. et al. 2016. Am J Transl Res. 8: 1027-36.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.